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ABSTRACT 
 
Different Methods for Particle Diameter Determination of Low Density and High 
Density Lipoproteins – Comparison and Evaluation. (December 2006) 
Vidya Vaidyanathan, B.Sc., Calcutta University; M.Sc., Avinashilingam University, 
India 
Chair of Advisory Committee: Dr. Rosemary L. Walzem 
 
 Predominance of small dense Low Density Lipoprotein (LDL) is associated with 
a two to threefold increase in risk for Coronary Heart Disease (CVD). Small, dense HDL 
(High Density Lipoprotein) particles protect small dense LDL from oxidative stress. 
Technological advancements have introduced an array of techniques for measuring 
diameters of LDL and HDL as well as estimating overall particle heterogeneity. 
However, there is lack of comparative studies between these techniques, and, hence, no 
conclusive evidence to establish the merits of one method relative to others. The primary 
purpose of this study was to compare Nondenaturing Gradient Gel Electrophoresis 
(NDGGE) and Dynamic Laser Light Scattering (DLLS) methods in determining LDL 
and HDL particle diameter. Our comparison entailed: 1) Evaluating the two methods in 
terms of their reproducibility 2) Correlating the two methods(in future studies method 
selection would be driven by time and cost considerations if the two methods correlate), 
and 3) Evaluating the two methods in terms of their ability to identify bi-modal samples. 
A secondary purpose of this research was to investigate the effect of refrigerated plasma 
storage on particle diameter. Reproducibility was measured as Coefficient of Variance 
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(CV). Within and between runs, CV for LDL and HDL for NDGGE were <6% and 
<15%, respectively and for DLLS, CV within runs were <3% and <5.5%, respectively. 
No correlation was observed between LDL diameter from the two methods. NDGGE 
showed two bands for 157 HDL samples of which only 24 samples showed bimodal 
peaks in DLLS. In order to study the effect of storage, three sample sets of LDL and two 
sample sets of HDL were used. NDGGE showed a significant difference between mean 
diameter of fresh and stored LDL and HDL sample for all sets, whereas DLLS showed a 
significant difference in only one LDL sample set and none for HDL sample sets. We 
conclude that DLLS may be a better method for measuring LDL diameter because 
NDGGE overestimated LDL diameter. However, NDGGE was able to resolve 
subpopulation better in an HDL sample than DLLS. Thus, NDGGE may be a better 
choice for measuring HDL diameter than DLLS.  
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CHAPTER I 
INTRODUCTION 
 
Atherosclerotic Cardiovascular Disease (ASCVD) is characterized by abnormal 
deposit of lipid and fibrin in the vessels which subsequently results in the thickening of 
vessel walls (1). Coronary Artery Disease (CAD) refers to a condition in which arteries 
supplying blood to the heart muscle are affected. Coronary Heart Disease (CHD) 
encompasses both CAD and the resulting complications from ASCVD like angina and 
heart attack. Elevated levels of low density cholesterol are known to be associated with 
increased risk for ASCVD(2). Conversely, high concentrations of high density 
cholesterol are known to protect against the development of ASCVD(3). More recently, 
attention has been given to the diameter of lipoproteins and their role in ASCVD. 
Several lines of evidence suggest that low density lipoprotein (LDL) diameter is an 
important predictor of cardiovascular events and progression of CHD. Evidence suggests 
that LDL physical properties (particularly small, dense LDL) as well as quantity may 
increase cardiovascular risk (4). Austin et al. used mathematical modeling techniques to 
separate LDL tracings on gradient-gel electrophoresis into individual underlying 
Gaussian curves of LDL subspecies. From this technique Austin et al identified two 
subclass patterns of LDL: phenotype A and phenotype B (5). Phenotype B has been 
found in 40-50% of heart attack victims and individuals with ASCVD (6). Phenotype B  
is characterized by a relatively small diameter (< 25.5nm) and high density (d = 1.050- 
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1.063 g/ml) whereas Phenotype A is characterized by a larger diameter (> 25.5nm) and 
more buoyant density (d = 1.025-1.033 g/ml) (6). 
The National Cholesterol Education Program Adult Treatment Panel III has 
recognized a predominance of small, dense low-density lipoprotein (LDL) as an 
emerging risk factor for ASCVD (7).  Predominance of small dense LDL is associated 
with a two to threefold increase in risk for CHD(8). Several epidemiological, perspective 
and case control studies support this estimate (9, 10). LDL exhibiting small dense 
phenotype B also possess an increased susceptibility to oxidative modification. This has 
been demonstrated by in- vitro studies which suggest that particles of a small diameter 
may directly promote atherosclerosis (6).  
Differential precipitation (11, 12)and particle diameter analysis using 
nondenaturing polyacrylamide gradient gel electrophoresis (NDGGE) have been used to 
identify subclasses of high density lipoprotein (HDL) (13). Differential precipitation was 
used to broadly classify HDL populations as a less dense HDL2, and a more dense 
HDL3. Particle diameter analysis has helped to refine population boundaries: HDL2a (8.8 
to 9.7 nm in diameter), HDL2b (9.7 to 12 nm), HDL3a (8.2 to 8.8 nm), HDL3b (7.8 to 8.2 
nm), and HDL3c (7.2 to 7.8 nm) (14). Dense HDL3 particles are smaller in diameter than 
the less dense HDL2 particles.  
The role of smaller, denser LDL phenotype B particles and their major 
apolipoprotein, apoB-100 in ASCVD (15) is well established.  A similar association 
between ASCVD and HDL particle diameter has not yet been established due to 
limitations imposed by biological variability, particle instability, and measurement error 
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with HDL subclasses (14). Miller (1987) showed that antiatherogenic property of HDL 
was associated with HDL2 subclass (16), and smallest HDL particles (HDL3b, c), have 
been associated with increased ASCVD risk in several studies (17).  
  On the contrary, several researchers have shown that small HDL particles 
possess antiatherogenic property (18).  According to the theory put forth by these 
researchers the reduced free cholesterol and phospholipid (PL) content of small HDL 
increases the ability of this particle class to efficiently remove cellular cholesterol. HDL 
expresses its antioxidative property chiefly through its apolipoprotein A-1 (apoA-1). 
Apo A-I delay or prevent LDL oxidation, or both, by removing the oxidized PLs from 
LDL, artery wall cells or both. Paraoxonase (PON 1), an antioxidative enzymatic 
component of HDL also protects LDL against oxidative modification by reducing 
formation of hydroperoxides in LDL (19).  
Technological advancements have introduced an array of techniques capable of 
measuring the diameters of LDL and HDL lipoproteins as well as estimating overall 
particle heterogeneity. Of these, NDGGE is most commonly used. Though accurate, this 
method is laborious and time consuming (20). Nuclear Magnetic Resonance (NMR) 
spectroscopy, Electron Microscopy (EM) and Dynamic Light Scattering (DLS) 
techniques are other methods of measuring particle diameter. However there is a lack of 
comparative studies between these techniques and hence there is no conclusive evidence 
to establish the merits of one method relative to others.  
In the present study we measured particle diameter of LDL and HDL by NDGGE 
and DLS. The principle underlying particle diameter measurement by DLS is light 
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scattering arising from Brownian motion of suspended particles. Particles suspended in 
liquid exhibit random Brownian movement. The rate of motion is inversely proportional 
to the diameter of the particles. Within light scattering measurement instruments, light 
emitted by the laser upon incident on the particles is reflected back to the detector. 
Depending on the motion of the particles the reflected light reaches the detector at 
different time interval depending upon light wavelength. The signal generated by the 
detector will resemble a noise signal due to the constantly changing diffraction pattern 
caused by destructive and constructive interference with incident light as the particles 
change their position. Analysis of the intensity fluctuations yields a diffusion coefficient 
(DT), which is related to particle diameter. In our case we will use a specialized form of 
DLS which employs an unshifted light control as a reference. This special technique is 
referred to as Dynamic Laser Light Scattering (DLLS). 
In NDGGE particle diameter is determined by the migration distance of the 
particles in the gel. In this application, gel is a porous media in which pore diameter is of 
the same order as the diameter of the particle under investigation in order to effect 
molecular sieving of individual lipoprotein particles. 
The primary purpose of this study is to compare NDGGE and DLLS methods in 
determining LDL and HDL particle diameter. Our goal was to determine whether the 
methods were comparable. Our comparison entailed: 
1) Evaluating the two methods in terms of their reproducibility. Reproducibility 
is an important characteristic for any technique and it is crucial to know the 
reproducibility of a method.  
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2) Method correlation: If the two methods correlate well then in future studies 
method selection would be driven by time and cost considerations.   
3) Evaluating the two methods in terms of their ability to identify bi-modal 
samples. LDL and HDL diameters have been associated with ASCVD. So it 
is important for a method to have the capacity to identify the distinct 
lipoprotein sub-populations, if any, in a sample. 
Based on our preliminary analysis we provide suggestions for future comparative studies 
between these methods.   
A secondary purpose of this research is to investigate the effect of refrigerated 
plasma storage on particle diameter. Our hypothesis is that particle diameter changes 
with storage. An observation of a change in the stored sample will substantiate this 
hypothesis. 
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CHAPTER II 
LITERATURE REVIEW 
  
 Lipoproteins are spheroid particles that consist of a nonpolar core of 
triaclyglycerides (TAG) and cholesteryl esters (CE) surrounded by an amphilicic coating 
of protein, PL, and unesterified cholesterol (UC) (21). The amphipathic nature of these 
particles makes them ideal lipid transporters in the polar environment of the blood (21). 
Lipoproteins are divided in five broad classes, based on the relative ratio of lipid to 
protein in the particle (22). These lipoprotein classes are typically characterized by 
density, composition, particle diameter, and particle mass and distinct apolipoproteins 
(Table 1). In this section we will limit our discussion to LDL and HDL. Reported effects 
of monounsaturated fats (MUFA) on the diameter of LDL and HDL will be discussed. 
Finally, a review of the different methods used for measuring lipoprotein diameter will 
be presented.    
Low density lipoprotein 
LDL are spherical particles with diameters ranging from 18-26 nm (23). The 
particle core is composed of CE and TAG, surrounded by a lipid coat of UC and PL. 
LDL contains approximately 20-25% protein, 15-20 % PL, 7-10% UC, 35-40% CE and 
7-10% TAG. The protein part which primarily comprises of apolipoprotein is embedded 
in the lipid coat. Apolipoprotein B100 (apoB100) is an essential structural protein for LDL. 
It serves as the ligand for the LDL receptor in peripheral tissues and liver. ApoB100 is a 
component of plasma Chylomicron (CM), Very Low Density Lipoprotein (VLDL), 
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Intermediate Low Density Lipoprotein (IDL) and LDL (24). LDL sometimes contains 
other small apolipoproteins, such as apolipoprotein CIII (apoCIII) and apolipoprotein E 
(apoE) that modulate LDL metabolism (25). The diameter of LDL depends on how 
much lipid is in the core, and the lipid content determines LDL density. Thus, smaller 
LDL is more dense, while the larger LDL contain greater fractional core lipid content 
and therefore are more buoyant (Table 2)(26).  Early studies using analytical 
ultracentrifugation determined that distinct LDL subpopulations are present in each 
individual (5).  
Formation of small dense LDL 
Very low density lipoproteins (VLDL) are the precursors for LDL particles (27).  
Plasma TAG concentration has been correlated with the diameter of VLDL and also the 
relative amount of each VLDL subclasses. The relative amount of large VLDL (VLDL1: 
Sf 60-400) (27) increases with increasing TAG concentration (28). Schneeman et al 
(1993) showed that 80% of the increase in lipoprotein particle number was accounted for 
by VLDL containing apo B100 after fat intake (29). This increase in number was confined 
to VLDL1 particles. Thus in hypertriacylglyceridemia (HTAG), there is an accumulation 
of VLDL1 in the plasma. Coronary artery disease patients were shown to accumulate 
large apolipoprotein C-I (apoC-I)-rich VLDL in their plasma after an oral fat- tolerance 
test. These subjects had an exaggerated postprandial TAG response to the fat-tolerance 
test (30).  Enrichment of VLDL1 with apo C-I was reported to delay particle clearance 
and cause an accumulation of these VLDL in plasma. In-vitro studies supported this 
suggestion, and have shown that apo C-1 enrichment of VLDL inhibits apoE- mediated 
   
  
 
8
uptake of VLDL by both the LDL receptor (LDLR) and the LDL receptor – related 
protein (LRP) (31). Thus, though VLDL1 have large amounts of apoE, the key ligand 
mediating VLDL uptake by hepatic cells, the presence of apo C-I in these VLDL inhibits 
the ability of apoE to bind to its receptors. Possibly apoC-I masks the receptor binding 
domain of apoE (30) or displaces apoE from the lipoprotein particle (31). In addition, 
Berbee et al. has shown that apoC-I inhibits lipoprotein lipase (LPL) mediated TAG-
lipolysis (32). Thus reduced binding of VLDL1 to its receptor along with decreased 
lipolysis of VLDL1 creates an environment ideal for the formation of small dense LDL 
(Figure 1) (27).  Triacylglycerol rich VLDL1 remain in circulation for a longer time 
because of its decreased clearance rate.  LDL formed from these VLDL1 have a greater 
residence time in blood (5 days) compared to LDL formed from normal VLDL (2 days) 
(27). This is because LDL from VLDL1 have an altered apoB conformation that reduces 
binding to LDL receptors (33). This increased residence time in the circulation allows 
LDL to undergo remodeling (27) and reduces oxidative stability (34). One important 
enzyme involved in the remodeling of LDL is CE transfer protein (CETP). It faciliates 
the loss of CE from LDL in exchange for TAG from VLDL. In the presence of slowly 
clearing VLDL1 there is increased transfer of TAG into LDL. In subsequent steps TAG 
is removed from LDL by Hepatic Lipase (HL). In case of increased hepatic lipase 
function, rapid removal of TAG from LDL leads to the formation of small dense LDL 
particles. Thus the key players in this model for generating small dense LDL are HTAG, 
CETP and HL (27) (Figure 1).  
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Modified function of small dense LDL 
Small dense LDL binds less efficiently to the LDL receptors. This is primarily 
due to structural modification in the apoB100 of LDL (33). Since apoB100 is the ligand for 
LDL receptor, its modification decreases the affinity of LDL towards LDL receptors. 
Thus small LDL remain in circulation for a longer time. Another functional modification 
of small dense LDL is it reacts more strongly with the arterial wall proteoglycans (35). 
This interaction leads to accumulation of LDL in the subendothelial space of the artery 
wall, further modification, and uptake by macrophages thereby promoting foam cell 
formation. Small dense LDL is also more susceptible to oxidation as it has less vitamin 
E. Oxidized LDL provokes inflammation that underlies atherosclerosis (36). 
Epidemiological studies linking LDL diameter and CAD 
Predominance of small dense LDL is associated with a two to threefold increase 
in risk for CHD (8). Case-control study of myocardial infarction supports this conclusion 
as risk of myocardial infraction was significantly associated with predominance of small 
dense LDL.  This association was independent of age, sex and relative weight. Subjects 
with increased small dense LDL also showed decrease in HDL-cholesterol (HDL-C) and 
increase in TAG and LDL-cholesterol (LDL-C). Small dense LDL was also shown to be 
associated with angiographically diagnosed CAD (9, 10, 37). Prospective studies 
involving three population cohorts demonstrated that reduced LDL particle diameter at 
baseline was a significant predictor for the development of CAD. But in most of the 
above studies the disease risk associated with small dense LDL was no longer significant 
after adjusting for TAG or other risk factors (9). 
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High density lipoprotein 
High Density Lipoprotein (HDL) are a class of lipoproteins whose primary 
function is to carry cholesterol from the body tissues to the liver for disposal. Human 
HDL contains approximately 40-55% protein, 20-35% PL, 3-4% UC, 12% CE and 3- 
5% TAG. HDL are the smallest of the lipoproteins (5-12 nm) (38). They are the most 
dense lipoprotein class because they contain the highest proportion of protein (Table 3). 
In humans, the two major apolipoproteins in HDL are apoprotein A-I (apo A-I) and 
apoprotein A- II (apo A-II). HDL can also be grouped into subclasses based on their 
particle diameter (14) (15) (16). The discoidal HDL particles are small, lipid-poor, 
nascent particles (7.5nm) (39). They are made of apolipoproteins and enveloped by a 
layer of PL and UC. Spherical HDL are larger because they contain core lipids and are 
enriched with CE and TAG. These heterogeneous subclasses of HDL perform different 
physiological functions in the body (38). 
Formation of small dense HDL 
Spherical HDL particles are generated from lipid-free apoA-I or discoidal HDL 
(38) which are mainly produced by the liver and intestine or can be released as surface 
fragments from TAG rich lipoproteins during lipolysis (40) (Figure 2)(41).  Nascent 
native HDL particles readily pick up cholesterol and PL at cellular membranes via efflux 
(40). The HDL cholesterol is subsequently esterified by the enzyme lecithin:cholesterol 
acyltransferase (LCAT) thus converting the nascent HDL into mature CE rich HDL (42). 
Cholesteryl ester from the mature HDL may be removed through several pathways. 
First, the CE in mature HDL maybe exchanged for TAG of apoB containing lipoproteins 
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via CETP (43). Second, there may be selective uptake of CE by the liver. This process is 
mediated by a separate class of scavenger receptors (44). Third, apoE-containing HDL, 
which constitute the minority of HDL, maybe internalized by hepatic apoE receptors 
(LDLR and LRP) (45, 46). Cholesteryl ester transfer protein facilitates the exchange of 
HDL CE for TAG in VLDL or chylomicrons. The subsequent action of HL on the TAG- 
rich HDL generates small, PL- rich HDL that are the optimal mediators of cellular 
cholesterol efflux (46). 
Function of small dense HDL 
Small, dense HDL particles protect small dense LDL from oxidative stress. 
Apolipoproteins and enzymes (like PON1) associated with HDL possess antioxidative 
properties which reduce formation of peroxides in LDL (47). This antioxidative property 
of the apo lipoproteins and enzymes are unevenly distributed across HDL subfractions, 
being more pronounced in small HDL (19). Consequently, small, dense HDL potently 
protects LDL against oxidative stress (19). Small HDL probably acquires oxidized lipids 
more efficiently than large HDL, because of their distinct cholesterol efflux capacity 
(48). 
Epidemiological studies linking HDL diameter and CAD 
Several studies have investigated the importance of HDL particle diameter as 
predictor of future coronary events (48). In the male participants of the Framingham 
Offspring Study, concentration of large diameter HDL particle was found to be lower in 
subjects with CAD than in control (49). In vitro studies have documented that small 
HDL are more potent in removing cellular cholesterol than large HDL (18, 50) and thus 
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concluded small dense HDL to be a more potent antiatherogenic agent. These studies 
have shown that in  metabolic diseases like Metabolic Syndrome (MetS) and type 2 
diabetes, the antiatherogenic property of the small dense HDL is the most affected (51). 
In insulin resistance small dense HDL showed TAG enrichment, CE depletion and 
attenuated antioxidative property. Attentuation of the antioxidative function of small 
HDL may not be the only consequence related to HDL in MetS. Studies show that in 
MetS the total concentration of HDL-C on the whole may be decreased (52) and 
subsequently less HDL maybe available to protect LDL against oxidation. Decrease in 
HDL concentration was measured by level of apoA in circulation and these studies 
showed that apoA-I concentration was decreased in MetS.  
Monounsaturated fat and particle diameter 
The effect of dietary fat on LDL -C concentration is well documented (53).  The 
effect of MUFA on LDL diameter has also received much attention. However, literature 
on the effects of MUFA on HDL particle diameter is limited. A study showed that HDL 
particle diameter did not differ significantly between Saturated Fat (SFA), MUFA and 
Polyunsaturated fat (PUFA) in fatty fed individuals. Healthy men and women 
participated in this randomized multiple crossover design study and were fed diets 
enriched with stearic acid, oleic acid, and linoleic acid (54). The main source of stearic 
acid in the stearic acid- rich diet was coco butter (33.5%), oleic acid enrichment was 
achieved with high oleic acid sunflower oil (47.0%), while linoleic acid enrichment was 
achieved with safflower oil supplementation (52.0%).  The diets provided 38% of total 
energy requirement from fat, of which 60% was supplied by the experimental fats.  
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Subjects were provided with a list of fat- containing food from which they could choose 
foods to meet their remaining 40% of the daily fat intake. Except for the 7% of energy 
specifically provided as stearic, oleic, or linoleic acid, the nutrients composition of the 
diets were the same across the three treatments. Each subject consumed one of the three 
diets for 5 wks followed by a washout period of > 1 wk before crossing over to the next 
diet. At the end of the experimental period, LDL and HDL particle diameters were 
measured using NMR spectroscopy. The result showed there was no significant 
difference of LDL and HDL particle diameter across the three fats. 
 Compared to HDL, dietary fat has been reported to alter LDL diameter in a 
number of studies. A study involving apparently healthy individuals showed that both 
MUFA and PUFA had similar effect on the diameter of LDL particles. Both dietary fats 
produced very small reduction in the diameter (55). In this parallel design study each 
individual consumed one of the three test fats – olive oil (rich in MUFA), rapeseed oil 
(rich in MUFA and PUFA) and sunflower oil (rich in PUFA) for four wks. At baseline 
each individual were required to consume a diet high in SFA for two wks. Subsequently 
subjects were randomly assigned to the three test fats.  Other than the different fatty acid 
composition all the three diets were identical. Energy percent from total fat was same at 
baseline and during the treatment. Energy percent from SFA was similar between the 
three test diets and was ~ 9% less than baseline. LDL diameter was measured using 
NDGGE after four wks of feeding experimental fat. It was shown that all endpoint LDL 
diameter was significantly smaller than baseline LDL diameter for all treatments (olive 
oil, 26.28 vs 26.36 nm; rapeseed oil, 26.11 vs 26.29 nm; sunflower oil, 25.89 vs 
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26.18nm), although no significant difference was noted in LDL diameters between the 
three diets at the end of the experimental phase. The study concluded that dietary MUFA 
and PUFA similarly reduce LDL diameter relative to SFA.  
Another study showed that LDL diameter increased in healthy subjects fed a 
Mediterranean diet, high in MUFA-fat compared with a low fat, high carbohydrate diet 
(CHO) (56).  Subjects were initialized on a saturated rich diet for four wks (47% CHO, 
38% fat, 20% SFA, 12% MUFA, 6% PUFA). At the end of four wks they were 
randomized into two groups. First group was assigned to a MUFA rich diet (47% CHO, 
38% fat, <10%, 6% PUFA, 12% MUFA). At the end of four wks, the group was put on a 
CHO rich diet (55% carbohydrate, <30% fat, <10% SFA, 6% PUFA, 12% MUFA). The 
second group was assigned to the high CHO diet first followed by the high MUFA diet. 
There was no washout period between the two diets in either group. At baseline LDL 
particle diameter was significantly larger in subjects with the apoE 4/3 genotype 
compared with those with apoE 3/3 and apoE 3/2 (Table 4)(56). There was a decrease in 
LDL diameter in subjects with apoE 4/3 after changing from a high-CHO diet to a 
MUFA-rich diet (26.47 vs 26.26), whereas in subjects with apoE 3/3 there was an 
increase (25.74 vs 25.91). The study concluded that high MUFA diet increases LDL 
diameter when compared to high CHO diet, but the effect was dependent on apoE 
genotype. The study did not compare LDL diameter among the two diets independent of 
genotype. In contrast to the above studies, some studies have documented no effect of 
MUFA on LDL diameter or have show that though MUFA-rich diets increased LDL 
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diameter, they caused more plaque in monkeys than PUFA. A few of these studies are 
described below in brief.  
The first study was done in a group of African monkeys (57). The objective of 
the study was to determine if MUFA was as effective as PUFA in limiting the 
development of coronary artery atherosclerosis. Monkeys were fed a challenge diet 
containing SFA (40% of total energy as lard) and cholesterol (0.8mg /kcal) for eleven 
wks. At the end of the challenge diet period, plasma concentrations of total cholesterol, 
VLDL-C, IDL-C, LDL-C, HDL-C, apoB, apoA-I, apoE, and LDL particle diameter were 
measured and monkeys with equivalent means were grouped together in order to create 
three experimental groups.  The challenge diet was followed by a 10-wk washout period 
in which monkeys were fed monkey chow diet. Subsequently each group was fed for 
about 5 years with experimental diets containing 35% of kilocalories as fat and 0.8 mg 
cholesterol/kcal. The diets differed only in the type of fat. Two diet periods with 
different degree of fatty acid enrichment was used (Table 5)(57). The degree of fatty 
acid enrichment was more exaggerated during the final 42 months (the longest period of 
the study, period 2). During period 2, the SFA diet, mainly palm oil contained 40% of 
the fatty acids as palmitic acid. The MUFA diet, mainly oleic acid–enriched safflower oil 
contained over 70% of the fatty acids as oleic acid. The PUFA fat diet, mainly safflower 
oil contained over 70% of the fatty acids as linoleic acid.  At the end of the study LDL 
were isolated by size exclusion chromatography and average LDL diameter was 
measured as LDL molecular weight. The LDL particles were large in the SFA fat group, 
were of comparable diameter in the MUFA fat group, and were smaller in the PUFA fat 
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group. The study also showed that at end of the 5 years of diet feeding, the 
atherosclerosis extent in MUFA-fed group was similar to that in the SFA-fed group, 
while the PUFA-fed animals had less. 
The second study was a clinical trial involving healthy, nonsmoking males 35 to 
55 years of age and postmenopausal females 50 to 60 years of age showed that MUFA 
enriched sunflower oil diet providing 40% to 42% of energy from fat, with 26% to 28% 
from MUFA and 40% to 45% of energy from CHO caused no significant change in the 
LDL diameter as compared to a low fat, high CHO diet providing 22% to 25% of energy 
from total fat, 7% to 8% of energy from MUFA and 55% to 60% of energy from 
CHO(58) . A group of subjects was randomly assigned to either of the diets for one 
month with a two-week washout period in between, during which subjects consumed 
their habitual diet. LDL diameter of the subjects was measured after each experimental 
period. No difference was observed in LDL diameter between subjects when consuming 
the high CHO diet (26.15 nm ± 0.23) and MUFA- enriched sunflower oil diet (26.20 nm 
± 0.23).  
The third study involved one hundred and sixty-two healthy Caucasian men and 
women within the age group of 30–65 years with normal or moderately increased body 
weight (59). Subjects consumed an isoenergetic diets, with same amount of total fat, but 
one diet had a high proportion of SFA while the other had a high proportion of MUFA. 
Both the diets derived 37% of energy from fat. The high SFA diet provided 17%, 14% 
and 6% of energy from SFA, MUFA and PUFA respectively. The MUFA diet provided 
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8%, 23% and 6% of energy from SFA, MUFA and PUFA respectively. LDL diameter 
did not differ in the two groups. 
        Thus, we see that while some studies reported an effect of MUFA on the LDL 
diameter, there are studies which have shown MUFA to have no effect on the particle 
diameter of LDL. 
 Methods to measure LDL and HDL diameter 
Diameter of LDL and HDL maybe used as risk determinants for ASCVD (8). 
Therefore, there is need for accurate methods to determine the diameter of these particles. 
A number of tools are available currently to assess the heterogeneity of LDL and HDL. 
Of these, NDGGE is the most commonly used method (60). Though accurate, this 
method is laborious and time consuming (20). Dynamic light scattering (DLS) technique 
is another particle diameter measurement technique which uses the principle of Photon 
Correlation Spectroscopy (PCS). Studies have showed good correlation of data obtained 
from NDGGE and DLS methods (61). Nanotrac®NPA250 (Microtrac, FL) is a particle 
size analyzer that uses DLLS to determine particle diameter distribution in a sample. 
Zetasizer® (Malvern Instruments, UK) 3000 is another particle diameter analyzer, which 
operated on the principle of Photon correlation spectroscopy (PCS). It is a DLS 
instrument. The basic difference between a DLLS and DLS is the former has a 
heterodyne configuration and the latter has a homodyne configuration. The two 
configurations will be described in later section. 
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Non-denaturing gradient gel electrophoresis 
The basic principle of gel electrophoresis is that charged particle migrates 
through a gel under the influence of an electric field. In this application, gel is a porous 
media in which pore diameter is of the same order as the diameter of the particle under 
investigation in order to effect molecular sieving of individual lipoprotein particles. In 
many applications, the separation is dependent on both charge density and particle 
diameter (or protein molecular weight) (62, 63, 64) .  
Different media are used for electrophoresis. In the present study, we used 
polyacrylamide gel. Polyacrylamide gel has number of advantages over other media like 
agarose and starch. Polyacrylamide gel is a synthetic polymer of acrylamide monomer, 
and is prepared from highly purified reagents in a reproducible manner if the 
polymerization conditions are standardized. Polyacrylamide gel is chemically inert, 
stable over a wide range of pH, temperature, and ionic strength, and is transparent. 
Polyacrylamide is better suited to a size fractionation of particles since the gels it forms 
can have a wide range of pore sizes. The effective pore size of polyacrylamide gels is 
determined by the total acrlyamide concentration in the polymerization mixture.  
Effective pore size decreases as acrlyamide concentration increases. Thus, two particles 
with widely differing diameters, but identical charge densities will separate on 
polyacrylamide gel cast to contain gradient of increasing acrylamide content as the 
molecular sieving effect would slow down the migration rate of the larger particle 
relative to that of the smaller particle (62). The electrophoretic conditions created by 
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 0.09 M Tris, 0.08M borate, 0.003 M Na2 EDTA, pH- 8.35, cause all applied lipoprotein 
particles to adopt a similar charge density.  Thus, particles separate according to their 
diameters. A gradient increases the range of diameter of particles that can be separated, 
and also causes sharpening of bands. The most extensively used gradient gel for 
lipoprotein separation are commercially prepared slabs with linear gradients of 2-16% 
for LDL and 4-30% for HDL (62).     
 Dynamic light scattering method 
Dynamic laser light scattering operates on the principle of PCS or Quasi-Elastic 
light scattering technique. Macromolecules suspended in liquid exhibit Brownian motion 
which scatter light causing either a constructive or destructive interference. The 
interference changes with the movement of the molecules causing a fluctuation in the 
intensity of the scattered light. The fluctuation ranges between zero and twice the 
average intensity. The rate of fluctuation depends on the velocity of molecules. The 
measurements of the change in fluctuation rates are thus used to calculate the transitional 
DT. Macromolecules are small fast moving particles, and thus scatter very little light, 
causing rapid intensity fluctuations. Diffusion coefficient is obtained by counting the 
individual scattered photons. These photons are counted into a channel or time window 
and autocorrelation of this data gives the intensity fluctuation constant. Once DT has 
been determined, the hydrodynamic radius, RH, can be calculated using the Stokes-
Einstein equation: 
               DT = kT/ 6πηRH 
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 Where k is Boltzmann’s constant, T is the absolute temperature and η is viscosity (65, 
66, 67, 68).  
Factors affecting particle diameter measurement 
Velocity:  Particle diameter is derived from the velocity distribution of the particles. 
Median velocity is inversely proportional to the particle diameter, i.e. small particles 
have a higher median velocity than large particles (65). 
Temperature:  It is obvious from Stokes-Einstein equation, that valid calculation of 
particle diameter depends on the absolute temperature of the fluid molecules in which 
the particles are suspended. Fluid molecules with high temperature have high average 
thermal energy and so will impart higher velocities to the particles during collision. 
Median particle velocity is directly proportional to the absolute temperature of the  
fluid.  
Viscosity: Particle velocity is inversely proportional to fluid viscosity. Viscosity is a 
complex but predictable function of temperature. If the operating temperature and 
viscosity at two temperatures spanning the operation interval are known, the viscosity at 
that temperature can be calculated. Thus, compensation can be made for both 
temperature, and fluid viscosity. The median particle velocities range from 5 micron per 
second to 6000 micron per second (65). 
Heterodyne and homodyne configurations 
Commercially available PCS instruments use two type of configurations, namely 
heterodyne and homodyne. In heterodyne configuration the frequency shifted light is 
mixed with stable, unshifted light (Figure 3) (65). The unshifted light is called the 
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reference light (or baseline) for the scattered, shifted light from each particle. The 
reference light originates from the laser and is reflected in the instrument to the detector. 
The interaction of the reflected and shifted light allows for removal of the high optical 
frequency present in the particle-scattered light. This leaves only the lower shifted 
frequencies, which are the values that are related to the diameter of the particles. 
          Homodyne detection uses a reference that is not stable and unshifted (Figure 3). 
The reference light actually denotes the light shifted by other randomly moving, unstable 
particles in the solution (65). 
Advantages/ disadvantages of heterodyne and homodyne configuration 
First in heterodyne configuration the power spectrum (frequency distribution) of 
particles depends upon twice the characteristic frequency of particle i.e. 2γ, while in 
homodyne configuration, power spectrum depends on γ. This means that a slight change 
in frequency of particle may result in a greater change in the power spectrum in 
homodyne configuration. Second, the homodyne power is proportional to the square of 
scattered light intensity, while the heterodyne power is proportional to the product of the 
scattered intensity and reference (laser) intensity. This implies that the heterodyne signal 
level can be made many orders of magnitude larger than the homodyne signal by 
providing a large reference beam using the reflected laser. This enables measurement of 
small particles through back scattering and also measurement of very dilute suspensions. 
In the present study we used Nanotrac®NPA250 (Microtrac, FL) particle size analyzer 
to determine particle diameter distribution through DLLS technique. The following 
section describes the operation of Nanotrac®NPA250.  
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Nanotrac®NPA250 operates on heterodyne configuration. Light from a laser 
diode passes through an optical beam splitter and strikes the sample. A sapphire window 
located at the probe tip forms an interface between the sample and the probe. The 
sapphire window has two functions. First, it reflects the original laser back through the 
optical beam splitter to a photodetector. This signal acts as a reference signal for 
detection as it has the same frequency as the original laser. Second, the laser passes 
through the sapphire window and is scattered by the suspended particles, which are 
moving in Brownian motion. The frequency of this laser is Doppler shifted relative to 
the velocity of the particles it encounters. Light is scattered in all directions including 
180 degrees backwards. This frequency shifted light is transmitted by the sapphire 
window through the optical beam splitter to the photodetector. These signals of various 
frequencies combine with the reference signal to generate a wide spectrum of 
frequencies. A high speed digital signal processor calculates the power spectrum of the 
interference signal. A power spectrum describes how the power of a signal or time series 
is distributed with frequency.The power spectrum is analyzed mathematically and the 
particle diameter distribution is calculated. 
           Some of the parameters obtained from Nanotrac®NPA250® NPA250 are:  
MV (Mean volume diameter) - Mean diameter in microns, of the volume distribution- 
represents the center of gravity of the distribution. This parameter is influenced by the 
presence of large particles in the sample. It maybe considered as a type of average 
particle diameter. 
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MI (Mean intensity diameter) - Mean diameter, in microns, of the intensity distribution- 
is calculated from the intensity distribution. Intensity mean does not take into 
consideration the effects of refraction and only reflects the relationship of the light 
signals detected. It is influenced by the intensity of the signals, and the value is displayed 
only when the intensity distribution is presented. 
MA (Mean area diameter) - Mean diameter, in microns, of the Area distribution is 
calculated from the volume distribution. This parameter is less influenced than MV by 
the presence of larger particles, and therefore shows smaller particle. MA is a particle 
surface measurement. 
MN (Mean number Diameter) - Mean diameter, in microns, of the number distribution- 
is calculated from the volume distribution data and is influenced by presence of small 
particles in a sample. This parameter is related more to the number of small particles in a 
population.  
Microtrac Nanotrac®NPA250 measurement approach 
The Microtrac Nanotrac® NPA250 operates on heterodyne detection. Figure 4 
(65) is a diagram of the Nanotrac®NPA250 measurement system. It shows the region of 
light interaction with the suspended particles. The Nanotrac®NPA250 has an optical 
beam splitter which ends on a sapphire window. The sapphire window is immersed in 
the suspension. The sapphire window delivers the laser beam to the sample. The 
sapphire window and optical beam splitter also collects light reflected back at 180°. The 
unshifted beam reflected at the interface between the sapphire window and the medium, 
is mixed with the back-scattered light. This unshifted beam provides the reference for 
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heterodyne detection. The high refraction index of sapphire produces a reflected 
reference beam with adequate intensity. There are two important features to this type of 
configuration. First, the high intensity reference beam allows the heterodyne component 
to dominate the power spectrum and to provide a signal which is much stronger than the 
equivalent homodyne signal. The high signal allows for the use of a silicon photo 
detector and a solid-state laser diode source which are very stable and reliable. 
The second important feature of Nanotrac®NPA250® is the scattered light signal travels 
a very short path length in the suspension. This allows measurement of high particle 
concentration while preventing effects of multiple scattering.  
Comparison between Nanotrac®NPA250 (Model NPA250) and Zetasizer® (Model 
3000) 
The frequency spectrum is uniquely determined by the particle velocity 
distribution that in turn is uniquely determined by the particle diameter distribution. The 
particle diameter distribution is calculated directly from the frequency spectrum obtained 
from the Doppler-shifted scattered light.  
          Transparent particles like LDL and HDL that have diameters less than 100nm are 
transparent and give rise to optical interference effects. Optical interference may be 
constructive or destructive. The amplitude of the signal received at the photo-detector 
will be larger if the interference is constructive and smaller if the interference is 
destructive. If the particles in a sample are of a single uniform diameter, optical 
interference is not a problem. The shape of the frequency spectrum is unaffected, 
resulting in the proper computation of particle diameter. Optical interference effects can 
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be significant if the particle distribution in a sample is bimodal, or if the particle 
population has a broad distribution of diameters. The computed particle diameter 
distribution would be distorted and skewed towards those particles that scatter light more 
efficiently. A true Volume distribution can be obtained when the distorting effects of the 
scattering efficiency function are properly compensated. If the distorted effects of the 
scattering efficiency function are not compensated, the resulting computed particle 
diameter distribution is more properly termed an Intensity weighted distribution. 
Instruments based on older technologies were unable to make the necessary104 
compensation and provided only intensity weighted particle diameter distributions. 
Nanotrac®NPA250 compute true volume distributions in the standard mode of operation 
and offer the user the alternative of selecting Intensity weighted or Mono-disperse 
modes of operation. The Nanotrac®NPA250 incorporates a highly accurate temperature 
sensor in the sample cell. By describing the fluid temperature and viscosity 
characteristics in the Nanotrac®NPA250 algorithm, these parameters can be included in 
determining accurate particle diameter distributions. Also, because the laser light needs 
only to penetrate approximately 100 microns into the sample to generate a power 
spectrum, the Nanotrac®NPA250 can accurately determine particle diameter 
distributions at significantly higher concentrations than other methods.  
           Zetasizer® (Model 3000) produces particle diameter information as Z-average 
size. The mean size or z-average is a intensity weighted mean. It is calculated from the 
signal intensity (69). This measurement can only be comparable to other techniques if 
the sample is monomodal (i.e. only one peak), spherical and monodisperse (i.e. no width 
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to the distribution), and the sample is prepared in the correct solvent. The instrument 
gives two values, a mean value for the diameter, and a width parameter known as the 
Polydispersity, or the Polydispersity Index (PDI). Polydispersity maybe defined as the 
state of nonuniformity in Molecular Weight (MW) of a material. It indicates whether the 
sample is composed of molecules with homogenous MW. A homogenous or a 
monodisperse sample has a polydispersity equal to1. A heterogenous or polydisperse 
sample is a mixture of species of different MW and has polydispersity that is different 
from 1. 
           The Z-average is a DT, which is converted to a diameter using the dispersant 
viscosity and some instrumental constants (68). 
For Zetasizer the cutoff PDI value for sample is 0.5.Thus the measurements from 
a Zetasizer® may give a more accurate description of the diameter that is comparable 
with other methods of analysis only if the samples are spherical and have a reasonably 
narrow distribution, i.e. with polydispersity below a value of 0.1. If the polydispersity is 
over 0.5, the Z-average mean may not be a reliable measurement, and a distribution 
analysis (using instruments like Nanotrac®NPA250) could be expected to provide more 
accurate peak positions (68). Nanotrac®NPA250 instruments uses advanced calculation 
to compute the full particle diameter distribution without a priori assumptions about that 
distribution and thus avoid the ambiguity of distribution approximation methods and 
assure maximum information about the sample particle distribution. In addition, because 
the laser light needs only to penetrate approximately 100 µm into the sample to generate 
   
  
 
27
a power spectrum, the Nanotrac®NPA250 can accurately determine particle diameter 
distributions at significantly higher concentrations than other methods.  
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CHAPTER III 
METHODOLOGY 
 
            Blood samples for our study were obtained from an ongoing study (main study) 
in our laboratory. 
Subject selection 
Thirty Texas A & M University faculty and students were recruited for the main 
study. The subjects were normal healthy males between the ages of 30 and 60 yr. 
Subjects were screened with a battery of blood chemistry tests including plasma glucose, 
BUN, major minerals, protein, albumin, bilirubin, alkaline phosphatase, aspartate 
aminotransferase, alanine aminotransferase,TAG, and all lipoprotein cholesterol 
fractions.  All subjects had total serum cholesterol values between 200 and 260 mg/dl, 
were non smokers and were not on restrictive diets or medication. All subjects were free-
living. Participants were advised of study risks and provided informed consent prior to 
study participation. The study was approved by the Institutional Review Board of Texas 
A & M University. 
Dietary intervention 
Preparation of ground beef 
Fat trim were collected at Texas A & M Rosenthal Meat Science & Technology 
Center from carcasses of Angus cattle fed either a corn-based, finishing diet (to 16 mo of 
age; MUFA: SFA ratio= 1.1), or a hay-based diet (to 20 mo of age; MUFA: SFA 
ratio=0.8), supplemented to attain a live weight of 500 kg at slaughter. Carcasses of 
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Angus cattle fed a corn-based diet to 24 mo of age (600 kg live weight) was the source 
of fat trim with the highest MUFA: SFA ratio (1.4). Cattle were adapted to their diets at 
weaning (8 mo of age). Fat trim was removed, vacuum –packaged, and stored frozen at -
80°C until used in ground beef formulations. Lean trim and fat trim were derived from 
carcasses available at the Texas A & M University Rosenthal Meat Science & 
Technology Center at the time of ground beef preparation. Each type of fat trim was 
ground separately with a Hobart grinder using a coarse (0.64 cm) grinding blade. Fat and 
lean trims were combined at appropriate ratios to yield 30 % total extractable lipid and 
reground using a fine (0.32 cm) blade. Ground beef patties (110g: 4 oz) were formed 
with an automated patty maker, quick frozen to -20°C, individually vacuum- packed and 
aged in polypropylene film. Final composition of the ground beef patties is given in 
Table 6. 
Experimental design 
Three groups of 10 men each were assigned randomly to one of the ground beef 
patties diets for 5-wk durations followed by crossover after habitual diet washout 
periods. The washout period was for 3wks to allow complete recovery from test diets. 
The 5-wk dietary periods excluded major holidays. A study phase was defined as the 
time prior to beginning of a 5-wk dietary period to the end of the 3-wk washout period. 
The study was conducted in three phases (Figure 5).  
Sample collection 
Fasting blood samples were collected at the start of each phase. (baseline), and 
again at the end of the 5-wk dietary period (endpoint). Within each baseline and 
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endpoint wk two blood samples were obtained. Therefore each subject had six baseline 
and six endpoint samples available for analysis (Figure 5). Table 7 shows the 
nomenclature used for labeling the six baseline samples and the six endpoint samples at 
three study phase.  
Diet instruction 
 Participants were instructed to incorporate the study beef into their diet with as 
little disruption as possible. No restrictions were placed on how the beef patty is to be 
prepared, but it was emphasized that all of the beef patty must be consumed within a 
single meal period. Participants substituted 110 g (4 Oz) of ground beef for the meat 
they typically consumed. Participants were required to consume one patty per day for a 
total of five patties in a wk.  Participants were frequently contacted by e-mail to provide 
updates and encourage compliance. On the day of the initial blood sampling each 
participant received an unlabeled box containing all of the patties necessary for each 5-
wk trial.  
Laboratory analysis 
Blood draw 
Plasma was harvested from blood collected into tubes containing EDTA, which 
prevents blood clotting and preserves plasma lipoproteins prior to their separation by 
sequential density gradient ultracentrifugation (20). LDL and HDL were isolated by 
sequential density gradient ultracentrifugation using human density intervals (20). 
Particle diameter distributions were measured in prepared LDL and HDL using two 
methods namely, NDGGE and DLLS. 
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Storage study 
To study the effect of storage on plasma lipoprotein diameter, 2ml of plasma 
from each of endpoint of phase I, baseline of phase II and baseline of phase III were held 
for four days at 4°C. At the end of 4 days they were prepared and analysized as were 
fresh plasma samples.  
Separation of plasma lipoprotein fractions 
Plasma lipoprotein separation was accomplished by density gradient 
ultracentrifugation. In this method lipoprotein separates into layers based on their 
density.  Particle with the lowest density has the greater non-polar lipid content within its 
core. As such, it has been shown that when centrifuged, larger TAG- rich lipoproteins 
rise to the top of the centrifugal field, while particles containing progressively less core 
distribute in a gradient fashion below. Thus VLDL +IDL with over 50% TAG, has the 
lowest density and the largest particle diameter when compared to LDL and HDL 
fractions (Table 1). This implies that lipoprotein density is inversely proportional to its 
diameter. 
Density solutions were constructed for separation of different lipoprotein 
fractions. At first a large volume of sodium chloride (NaCl) stock solution was made 
with the same molar background density as plasma (1.0063gm/ml). Distilled water was 
used for making the solution and the entire preparation was done under sterile 
conditions. Other, progressively more dense solutions were constructed from this stock 
solution by adding NaBr. All density solutions were measured with a digital density 
meter (Mettler/Parr, DMA 46, Graz, Austria). Saline solutions with given densities were 
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added to plasma samples in order to reach final densities of 1.026g/ml, 1.063g/ml, and 
1.216g/mL for VLDL+ IDL, LDL and HDL fractions, respectively. Balanced centrifuge 
tubes were placed in a Sorvall 45.6 TFT rotor (Sorvall-Dupont, Wilmington, DE), spun 
in a Beckman L8M Ultracentrifuge at 40K rpm (272,000g), and 14°C for 18 hours. HDL 
was spun at 14°C for 24 hours. The first ml of each fraction was carefully aspirated and 
was used for measuring particle diameter.  
Analysis of particle diameter 
I) NDGGE:  NDGGE is an external standard method that was used to indirectly estimate 
LDL and HDL particle diameters for all the samples. In this method particle diameters 
are estimated from a standard curve constructed from the migration distance of globular 
protein standards of know diameter.  
We employed the method of Nicholas et al (20). Briefly, 20µl of lipoprotein 
fractions were mixed with 5 µl of sucrose/dye solution (40% sucrose, 0.01 % 
bromophenol blue) to facilitate sample application.  A vertical electrophoresis apparatus 
was used for the experiment (Model GE-2/4 LS, Pharmacia, Uppsala, Sweden).  
Polyacrylamide gradient gels (Alamo Gel San Antonio TX; 2-16% for LDL, 4-30% for 
HDL) were loaded with the sample and standard proteins. Standard proteins of known 
hydrated diameter were used as calibrators (High Molecular weight standards, 
Amersham Pharmacia, Piscataway, NJ)(20). Prior to actual run, the gels were 
equilibrated in a buffer solution (41.01 gm Trizma base®, 19.17 g boric acid, 3.5 g 
EDTA and 0.73 g sodium azide, pH 8.3, 4L) for 30 minutes (70 volts, 40 ampere 
current, 4°C). The samples and the standards were loaded into the wells at the top of 
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each gel prior to application of 125 volts for 24 hrs at 4°C. Separated lipoprotein bands 
were stained overnight with 0.05% Coomassie Blue R-250 in methanol:acetic acid:water 
(45:10:45). The gels were destained with methanol –acetic acid – water (20: 5:75) 
solution. Individual gels were digitized using an Odyssey (LiCor, Lincoln NB) imaging 
device and associated software. Each band center was identified manually and the 
software then calculated the migration distance of the band center from the top of the 
gel.  Particle diameters were calculated in the digitized scans by comparison with 
migration distances of standard proteins of know hydrated diameter: thyroglobulin 
(17.00 nm), apoferritin (12.20 nm), catalase (10.40), lactase dehydrogenase (8.16) and 
bovine serum albumin (7.10). For calculation of the diameter of LDL the three larger 
standards (thyroglobulin, apoferritin and catalse) were used and for calculating HDL 
diameter all the five standards were used.  
Chicken VLDLy contains apoVLDL-II which is an inhibitor of LPL. So these 
particles can resist the intermediate metabolism of TAG hydrolysis and remain very 
stable in composition and diameter (70) regardless of lipoprotein age or turnover rate. 
This uniformity in diameter produces a narrow or “monodisperse” distribution range. So 
the diameter of a chicken VLDLy sample was determined using DLLS. Diameter of the 
same sample was determined by NDGGE using the standard curve of the five standard 
proteins. This information was used to construct two separate standard curves - one 
using chicken VLDLy diameter measured by DLLS and the standard proteins and the 
second using chicken VLDLy diameter measured by NDGGE and the standard proteins. 
LDL diameter of few samples were measured using the two standard curves with the 
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chicken VLDLy and also the original standard curve without the chicken VLDLy. Our 
purpose was to see if there was a significant change in the diameter of LDL if a standard 
was introduced that was larger than 17nm in diameter. Particle diameter of LDL was 
also calculated from a standard curve constructed by plotting logarithm of radius against 
the distance migrated relative to that of apoferritin or Rf. Rf of apoferritin was set at 1.0. 
II) DLLS: The first milliliter of each isolated lipoprotein fraction was used to measure 
the particle diameter distribution. Samples were measured in triplicate with each 
measurement allowing 1 minute for signal collection. Particle refractive index, fluid 
refractive index and viscosity of the suspending fluid at 20°C and 26°C solution were 
provided to the software (Table 8). Prior to sample analysis, set zero was established by 
analysis of the suspending fluid free of lipoproteins. The suspending fluid, or the 
background solution, was composed of the same salt solution and was of the same 
density as that in which lipoproteins were suspended. This step is necessary to 
compensate for background solution light scattering. Averages from triplicate 
measurements were used for statistical analyses.  
Statistical analysis of data 
Measurement of LDL diameter from DLLS were excluded if they were <16nm or 
> 28nm. For HDL, DLLS measurements were excluded if they were <7 nm or >14 nm.  
The Loading Factor (LF) and Concentration Index (CI) of discarded samples were 
compared to included data to see if the two were significantly different. Particle diameter 
of LDL obtained from NDGGE which had a chicken VLDLy (measured by DLLS) as a 
standard was correlated with MV, MN, MA and 50th percentile of MN distribution of 
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LDL diameter measured by DLLS to see which of the four correlated best with NDGGE 
measurements. Similar correlation was done for HDL. Chicken VLDLy diameters 
obtained from NDGGE and DLLS were compared. LDL diameter measured from the 
standard curve with chicken VLDLy (diameter measured by NDGGE) as a standard was 
compared to LDL diameter obtained from a standard curve that did not have chicken 
VLDLy as a standard. LDL diameter obtained from the above two standard curves was 
also compared to LDL diameter obtained from the standard curve which had a chicken 
VLDLy as a standard but the value of diameter of the chicken VLDLy was obtained 
from DLLS. The LDL diameter obtained from all of the above curves were compared to 
the LDL diameter obtained from the standard curve obtain by plotting log(r) against Rf 
of standards. 
      To determine the effect of storage on particle diameter, particle diameters measured 
using fresh samples were compared with diameters measured using samples stored at 
4°C for four days. The LF and CI of stored sample were compared with that of fresh 
samples to see if there was a significant change. The number of HDL bands resolved on 
NDGGE was compared with the number of HDL samples for which DLLS found 
bimodal peaks. Our aim was to determine if DLLS showed bimodal peaks for samples 
that had double bands in NDGGE. We were also interested to know if the width of the 
samples identified as bimodal by NDGGE but not by DLLS were greater than the width 
of samples with single bands in NDGGE and monomodal in DLLS. For this we 
compared thirty monomodal HDL samples from DLLS which showed two bands in 
NDGGE to thirty monomodal HDL samples from DLLS which showed one band in 
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NDGGE.  Measurements from NDGGE and DLLS were evaluated for reproducibility by 
using the coefficient of variation (CV) as calculated from the arithmetic mean ( X ) and 
standard error of mean (SEM) where CV= ( X
SEM
) 100%.  For NDGGE, CV for within 
runs and between runs was calculated using the relative migration values for the 
standards. For DLLS, CV among runs were calculated using the triplicate measurements 
of a sample. Paired, two-tailed t-tests were done using SPSS software for comparisons 
and p<0.05 were considered as significant.  
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CHAPTER IV 
RESULTS 
 
Subjects  
 Twenty-eight out of the thirty subjects, who participated in the study, 
successfully completed it. Two of the participants were unable to complete the study due 
to illness not related to study.  
Data exclusion 
 For DLLS, data of the 28 subjects were further scanned to remove suspect data. 
For LDL, a sample run was discarded if its corresponding MN value was < 16nm or > 
28nm. Further if all three runs of a single measurement had a MN value less than 16nm, 
then that particular sample was discarded. Similarly, for HDL a sample run was 
discarded if its corresponding MN value was < 7nm or > 14nm. Thus if all three runs of 
a single measurement had a MN value < 7nm or > 14 nm, then that particular sample 
was discarded. Finally for both LDL and HDL, data were also excluded if they were 
incomplete i.e. if the subjects missed any of the twelve draws (six baseline draws and six 
endpoint draws).  Table 9 summarizes the criteria for exclusion of data and also 
indicates how many of the analysis were excluded at each collection point based on each 
criterion. Note from the Table that more HDL analyses were discarded than LDL as they 
did not meet our criteria.  
Thirty excluded and included DLLS measurements were randomly selected for 
both HDL and LDL. The corresponding LF’s and CI’s were compared (Table 10). The 
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mean LF for included and excluded measurements were 0.1. Loading Factors of both 
included and excluded HDL analysis were < 0.1 and there was a significant difference 
between the LF factors for excluded and included analysis of HDL (p<0.05). Difference 
in concentration indices between excluded and included analysis for both LDL and HDL 
were significantly different (0.8 vs 0.3) (p<0.05). For NDGGE none of the LDL and 
HDL data were discarded.  
Comparisons between NDGGE and DLLS 
Reproducibility 
Reproducibility of the two methods was determined (Table 11). For NDGGE, 
CV of LDL for both within and between runs was < 6% and for HDL, CV for within and 
between runs was < 15%. CV within runs for DLLS was calculated for MV, MN, and 
MA of both LDL and HDL. CV of LDL for within runs was < 3% for MV, MN, MA and 
CV of HDL for within runs was < 5.5% for MV, MN and MA. 
Overall Mean Diameter of LDL and HDL 
Mean diameters of LDL and HDL were obtained from the two methods. To 
calculate the mean, measurements of all 12 collections were pooled together. Samples 
which were suspect were discarded before calculating the mean. For HDL samples 
which showed two bands on NDGGE, the average diameter of the two bands was 
calculated and that single value was used for computing the mean. The mean diameter of 
LDL as measured by NDGGE and DLLS is presented in Table 12.  Mean diameter of 
LDL measured by DLLS was smaller than that measured by NDGGE (19.1 vs 26.2 nm). 
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Mean diameter of HDL measured by DLLS matched the mean diameter of HDL 
obtained by NDGGE (9.8 nm vs 9.8 nm).  
Comparison between baseline pairs and endpoint pairs for each Phase 
 Means of the two measurements obtained at baseline for each phase were 
compared to each other to see if there was any significant difference. Similar comparison 
was done for the two endpoint measurements within each phase (Table 13).  If there was 
a significant difference between the baseline pairs and between the endpoint pairs, we 
were interested to know if both NDGGE and DLLS were able to detect the difference. 
Table 12 shows all six pairs of comparison made.  For LDL, four of the six 
comparisons showed no significant difference between the means for both NDGGE and 
DLLS. For the two pairs of comparisons which were significantly different, the endpoint 
pair of LDL for phase I (P1E1 & P1E2) were found to be significantly different by 
DLLS (19.8 nm vs 20.4 nm, p<0.05) but not by NDGGE (27.2 nm vs 27.1 nm, P>0.05). 
NDGGE showed a significant difference in endpoint pair of Phase III (P3E1 & P3E2) 
(27.2 nm vs 26.7 nm, p< 0.05) but not DLLS (19.8 nm vs 19.6 nm, p>0.05).  
For HDL, four of the six comparisons showed no significant difference between 
the means for both NDGGE and DLLS. Baseline pair of Phase III (P3B1 & P3B2) was 
found to be significantly different by DLLS (10.6 nm vs 9.0 nm, p<0.05) but not 
NDGGE (9.5 nm vs 9.3 nm, p> 0.05). NDGGE showed a significant difference in the 
baseline pair of phase II (9.5 nm vs 10.0 nm) but DLLS did not show any difference in 
this pair. 
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Correlation between NDGGE and DLLS 
 No significant correlation was obtained between MV diameter of LDL obtained 
from DLLS and mean diameter obtained from NDGGE (Figure 6), between MN 
diameter of LDL obtained from DLLS and Mean diameter obtained from NDGGE 
(Figure 7), or between MA diameter of LDL obtained from DLLS and mean diameter 
obtained from NDGGE (Figure 8). Further, no correlation was found between the 
median (50% percentile of MN) diameter of LDL obtained from DLLS and mean 
diameter of LDL obtained from NDGGE (Figure 9). In contrast a good correlation was 
obtained between MV diameter of HDL obtained from DLLS and mean diameter 
obtained from NDGGE (Figure 10), between MN diameter of HDL obtained from 
DLLS and mean diameter obtained from NDGGE (Figure 11), and between MA 
diameter of HDL obtained from DLLS and mean diameter obtained from NDGGE 
(Figure 12) and median (50% percentile of MN) diameter of HDL obtained from DLLS 
and mean diameter of HDL obtained from NDGGE (Figure 13). 
Estimation of chicken VLDLy diameter by DLLS and NDGGE 
DLLS has been used extensively to measure diameter of VLDLy (71, 72, 73) .  
In our study VLDLy diameter measured by DLLS was ~ 30 nm which agrees with the 
value reported by Walzem & Perry & Griffin (70). Mean chicken VLDLy diameter 
obtained on NDGGE was greater than that estimated by DLLS (37.7 nm vs 24.6 nm) 
(Table 14). Note that MV for chicken VLDLy from DLLS was closest to diameter 
measured by NDGGE. 
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Diameter of LDL obtained from standard curves with and without chicken VLDLy as 
standard 
Mean LDL diameter measured from standard curves with and without inclusion 
of chicken VLDLy diameter as a standard is shown in Table 15. Mean LDL diameter 
measured from the standard curve in which chicken VLDLy diameter obtained from 
DLLS was used as standard, was much smaller (18.4 nm) than the mean LDL diameter 
obtained from the standard without chicken VLDLy (Table 15). 
Bimodal Peaks obtained for HDL in NDGGE and DLLS 
 NDGGE showed double bands for 157 HDL samples. Of these, 24 samples also 
showed bimodal peaks in DLLS. There was no significant difference between the width 
of HDL samples with monomodal peaks in DLLS but two bands in NDGGE and HDL 
samples with bimodal peaks in DLLS and one band in NDGGE (Table 16).  
Effect of storage on LDL and HDL diameter 
For LDL effect of storage was studied using three different sample sets. NDGGE 
showed a difference between mean diameter of fresh and stored LDL sample for all 
three sample sets, while DLLS showed a significant difference in only baseline of phase 
III (Table 17).  For NDGGE there was a decrease in mean LDL diameter after storage 
for endpoint of phase I (26.3 nm vs 25.8 nm) and baseline of phase II (25.7 nm vs 25.1 
nm) while an increase in mean LDL diameter after storage was observed for baseline of 
phase III (25.6 vs 27.6 nm).  
             DLLS showed a significant difference in the LDL diameter between fresh and 
stored samples for phase III baseline. Mean diameter of fresh LDL sample was less than 
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the mean diameter of stored sample( 19.0 nm vs  21.0 nm).There was no significant 
difference between the diameter of fresh and stored LDL samples of phase I endpoint 
(19.8 nm vs. 19.3 nm) and phase II baseline (19.9 nm vs. 20.0 nm). 
 For HDL effect of storage was studied using two different sample sets. NDGGE 
showed significant difference between mean diameter of fresh and stored sample for 
both the sample sets (Table 18). Mean diameter of stored HDL samples were smaller 
than the diameter of fresh samples in phase I endpoint (8.9 vs 9.4 nm) and  phase II 
baseline ( 9.1 nm vs 9.4 nm).  In DLLS no significant difference was observed  between 
fresh and stored HDL samples  at endpoint of phase I  ( 9.9 nm vs 9.4 nm) and baseline 
of phaseII ( 9.1 nm vs. 8.6 nm ).  For DLLS mean diameter of HDL increased in the 
stored sample for endpoint of phase I. To check if there was a change in LF and CI in the 
stored samples, CI and LF of thirty of the samples for LDL and HDL were compared to 
fresh samples. There was no significant difference in the LF (0.1 vs 0.1) and CI (0.8 vs 
0.7) for LDL. No significant difference was observed in the LF (0.01 vs 0.01) and CI 
(0.3 vs 0.7) for HDL (Table 19).    
Overall CV of LDL and HDL measurements 
 Overall CV for LDL was less for NDGGE than DLLS (1.8 vs 3.2). Overall CV 
for HDL was also less for NDGGE than DLLS (2.6 vs 5.4). 
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CHAPTER V 
DISCUSSION 
 
 Aim of this study was to compare NDGGE and DLLS methods for measurement 
of LDL and HDL particle diameter. Our goal was to determine whether the methods 
were comparable. 
Exclusion of LDL and HDL readings 
LDL and HDL diameters are an important predictor of CVD. Evidence suggests 
that small dense LDL are the atherogenic subpopulation of this class of lipoprotein (5). 
Measurement of LDL diameter has been suggested as an important component of risk 
assessment for CVD.  Nondenaturing gradient gel electrophoresis and DLS has been 
used to measure has been used to measure the diameter of LDL (60) (61). These two 
techniques show good correlation with each other (60). Electron microscopy have 
determined mean diameter of LDL to be about 20 nm (74). LDL diameter by DLS has 
shown diameter of about 23.1nm, and NDGGE have shown diameter of about 26.1nm 
(61). Thus we see that depending on the technique used to measure LDL diameter its 
value could range from anywhere between 19 nm to 26 nm.  Based on this information 
we fixed the range of LDL diameter obtained from DLLS between 16 nm and 28 nm and 
any measurement out of this range was discarded. 
For HDL, mean diameter by DLS have been reported to be around 9.8nm (75). 
This is in close agreement with values obtained from nuclear magnetic resonance 
spectroscopy (9.2 nm) (76) and gradient gel electrophoresis (8.4 to 9.6nm) (77). In our 
   
  
 
44
study we fixed the lower limit of HDL as 7nm and values < 7nm were discarded.  Values 
> 14nm obtained from DLS are inconsistent with the mean values obtained for HDL and 
were also found to be irreproducible (75), therefore any values of HDL diameter > 14nm 
were also discarded from the sample set. 
 Loading Factor is a measure of the total signal obtained from the light scattered 
by particles in motion. Concentration index is a measure of amount of particle in a given 
amount of solvent. Mictrotrac recommends a LF between 0.1 to 100 for all samples. 
Within this range the instrument can cover a wide domain of CI. However for LF < 0.1, 
CI could be a concern for instrument limitations.  We hypothesized that LF and CI of 
LDL and HDL data whose diameter did not meet inclusion criteria may be significantly 
different from the LDL and HDL data that did meet the inclusion criteria. While the 
mean LF for LDL was within the range recommended by Microtrac, the mean LF for 
HDL was much less then 0.1 (Refer Table 10). Thus, LF is not a universal index for 
measurement quality. It is interesting to note that CI of those samples whose diameter 
measurements met the inclusion criteria for both LDL and HDL were greater than 
included data. It is possible that an increase in CI limited the function of DLLS. This 
may have resulted in exclusion of more HDL data. We conclude from our results that CI 
is an important factor in measuring a sample. 
Comparison between NDGGE and DLLS 
Precision and reproducibility of the two methods 
Precision of an instrument is defined as a measure of variance in repeated 
measurements on the same sample. Even when the accuracy of an instrument cannot be 
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determined, precision can prove to be a useful criterion for assessing the performance of 
an instrument. It is common to have good precision but poor accuracy (78). 
Reproducibility may be defined in terms of the variance observed from sample-to-
sample, instrument-to-instrument or operator-to-operator, etc (78). Both NDGGE and 
DLLS measures LDL with better precision than HDL as was observed from their CV 
within runs.(Refer to Table 11). Note that in NDGGE, HDL standards with smaller 
diameter were measured more precisely than standards with larger diameter. A similar 
trend was observed by Perusse et al (79) This may suggest that smaller HDL may be 
measured with better precision that larger HDL by NDGGE. For DLLS as observed 
earlier, more HDL data were excluded as compared to LDL data. The increased CV for 
HDL as compared to LDL confirms further that DLLS is not very precise in reading a 
HDL sample.  
A comparison of CV of NDGGE and DLLS for within runs shows that DLLS is 
better than NDGGE for measuring LDL .But again the imprecision in NDGGE could be 
due lack of appropriate standards. For DLLS, CV within runs for HDL was comparable 
to CV within runs for HDL from NDGGE. However, as the diameter of the standards 
increased CV of HDL from NDGGE became larger. Though the CV of NDGGE was 
greater when measuring larger standards, it would still be a better choice than DLLS for 
measuring HDL because DLLS gave a number of excluded data for HDL as discussed 
earlier.  
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Mean diameter of LDL and HDL 
Mean LDL diameter obtained from DLLS fell within the ranges reported for 
LDL diameters obtained by DLS and electron microscopy (61) (74).  DLLS measured 
LDL diameter matches closely with values obtained by electron microscope (Refer to 
Table 11). Reported mean values of LDL measured by NDGGE matches closely with 
the values we obtained for LDL diameter by NDGGE (26.2 nm)(61). Our results further 
corroborate previous study which showed the LDL diameter as measured by NDGGE is 
greater than that obtained by DLS (61). With the assumption that electron microscope 
gives the most accurate results for LDL diameter, DLLS could be a better choice for 
measuring LDL as compared to NDGGE.  
             For HDL, the average diameter obtained from DLLS was 9.8nm which agrees to 
value reported by Lima et.al using the same method (75). HDL diameter obtained from 
NDGGE in this study also agrees closely with values reported in earlier studies (76) 
(77). On the other hand many of the HDL data from DLLS were unreliable and it is 
possible that CI of samples greatly influence the way DLLS measures the sample. 
Therefore, CI of a sample has to be considered when measuring by DLLS. In contrast, 
CI is not a limitation with NDGGE. Hence NDGGE might be a better choice for 
measuring diameter of HDL. 
Comparison between baseline pairs and endpoint pairs for each Phase 
  Paired baseline samples were collected with a gap of one day between collection 
days. This was also true for paired endpoint pair samples. Given the short interval 
between the two collection days, we predicted that there would be no difference in the 
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values of the measurements of each individual sample in a pair. Indeed these results 
show that there was no significant difference between the two collections for majority of 
the pairs (four out of six).  Significant difference was seen between LDL pairs (P1E1 
and P1E2) for DLLS (19.8 nm vs 20.4 nm, p<0.05) and LDL pairs (P3E1 and P3E2) for 
NDGGE (27.2 nm vs 26.7 nm, p<0.05). For HDL significant difference was seen 
between P3B1 and P3B2 for DLLS (10.6 nm vs 9.0 nm, p<0.05) and P2B1 and P2B2 for 
NDGGE (9.5 nm vs 10.0 nm) (Refer to Table 13). These differences could be due to 
technical oversight like incorrect aspiration of LDL fraction from the centrifuge tube or 
presence of contamination in the sample. Since both NDGGE and DLLS showed no 
difference between the two collections for majority of the pairs, we may conclude that 
both DLLS and NDGGE were consistent in their readings. 
Correlation between NDGGE and DLLS 
We did not find any significant correlation of mean LDL diameter between 
NDGGE and DLLS. This is in contrast to the findings of O’Neal who obtained good 
correlation using the two methods. In our study we used standards which have been used 
in other studies (20),(61). Our standards have a range from 17 to 7.1 nm. Unlike other 
studies we did not have any standard beyond 17nm. Since LDL diameter is typically 
beyond 17nm which is outside the standard curve, we extrapolated the diameter from our 
standard curve. We assume that beyond a certain range of standard curve extrapolation 
may not produce accurate values for a sample. To eradicate error due to extrapolation we 
introduced a chicken VLDLy standard to extend the range of the standard curve. We 
constructed two standard curves- one using chicken VLDLy standard measured by 
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NDGGE and another using chicken VLDLy standard measured by DLLS. We failed to 
observe a correlation between mean LDL diameters obtained from the above two 
standard curves and mean LDL diameter values obtained from DLLS. A possible 
explanation for this observation could be, chicken VLDLy standard (measured by 
NDGGE using extrapolation method) in itself may not be accurate. For the standard 
curve that had chicken VLDLy measured by DLLS, migration of chicken VLDLy cannot 
be calculated similar to the other five standard proteins as the diameters of these five 
standard proteins was determined by a different method. 
 Diameter of Chicken VLDLy measured in NDGGE and DLLS  
Diameter of chicken VLDLy obtained from NDGGE was significantly larger 
then diameter obtained from DLLS (Refer to Table 14). This may suggest that NDGGE 
may overestimate the diameter of LDL particles. Others have noted discrepancies 
between LDL diameters estimated by EM and NDGGE (60, 61).  
Diameter of LDL obtained from standard curves with and without chicken VLDLy as 
standard 
The values of LDL diameter obtained from standard curve which used the 
diameter value of chicken VLDLy (obtained by DLLS) as one of the standards, was 
much smaller when compared to standard curve without chicken VLDLy and was also 
smaller when compared to standard curve which used the value of chicken VLDLy 
diameter obtained from NDGGE (Refer to Table 15). LDL diameter obtained from a 
graph of log(r) vs Rf were greater than that obtained from standard curve with and 
without chicken VLDLy( Refer to Table 15). We used chicken VLDLy as a standard so 
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that we could get a wide range on the standard curve. But the diameter of chicken 
VLDLy was measured by NDGGE which as we discussed earlier overestimates the 
measurement. Technically, the standard curve did not have a standard protein whose 
diameter was larger than 17 nm. In studies, which have used standards to cover the range 
beyond 17nm, the standards either were made in the lab or were purchased from 
manufacturers who no longer make those standards. NDGGE may give better results for 
LDL diameter if appropriate standards are used. However, obtaining suitable standards is 
a challenge. 
Bimodal Peaks obtained for HDL in NDGGE and DLLS 
NDGGE is more sensitive in resolving HDL subpopulations in a sample than 
DLLS because NDGGE showed double bands for 157 HDL samples of which DLLS 
resolved bimodal peaks in only 24 of the samples. Since there was no significant 
difference in the width of monomodal samples from DLLS which showed two bands in 
NDGGE and bimodal samples from DLLS with two bands in NDGGE, we concluded 
that DLLS could not affectively resolve two populations in a sample if the population 
was bimodal.  So NDGGE may be the preferred method for measuring HDL. 
Effect of storage on LDL and HDL diameter 
 Changes in structure and composition of lipoprotein have been reported in 
stored plasma (80). We hypothesized that a significant difference would be found in 
comparisons between fresh and stored samples. For NDGGE a change in LDL was 
obtained in all the three collections but DLLS showed a significant difference only for 
one collection (Refer to Table 17). For HDL, NDGGE showed a significant difference in 
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diameter between stored and fresh sample in both the collections but DLLS showed no 
significant difference in either of the collections (Refer Table 18).To better explain the 
results of DLLS we noted the CI of stored samples. We assumed that DLLS would have 
detected a difference if there was variation in CI. We found no significant difference in 
CI for either LDL or HDL (Refer to Table 19). We assumed that the change in the 
diameter caused by storage was too small to cause any significant change in the amount 
of light scattered by these particles. Since DLLS measurement is based on the amount of 
light scattered by these particles, we did not see any significant change in LDL and HDL 
diameter when measured by DLLS. NDGGE on the other hand measures particle 
diameter relative to the particles migration on the gel. A small change in the particle 
diameter may have resulted in an appreciable change in the migration of particle in the 
gel and so NDGGE was able to detect the change in particle diameter. We conclude that 
storage did cause a change in the particle diameter of both LDL and HDL and NDDGE 
was able to detect the change but not DLLS. 
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CHAPTER VI 
CONCLUSION 
 
LDL and HDL diameter is an important risk factor for CVD. As such to 
determine an accurate method for determining the diameter of LDL and HDL is very 
important. From our study we conclude that DLLS gave reliable reading for LDL and 
may be used for measuring the diameter of LDL. NDGGE on the other hand 
overestimated the value of LDL diameter. But the primary reason for this was lack of 
appropriate standards. This problem of overestimation could be solved with use of 
suitable standard. But given the not so ready availability of such standards, this process 
may be tedious and expensive. NDGGE may be a better choice for measuring HDL than 
DLLS. DLLS gave a large number of excluded HDL samples. This may be because 
DLLS depends on CI of samples and any technical error or contamination of sample that 
may cause a change in CI of sample may affect the results obtained from DLLS. This is 
not the case with NDGGE as this method is CI independent. NDDGE was able to 
resolve the subpopulation in a HDL samples better than DLLS. NDDGE detected a 
refrigerated storage effect in LDL and HDL while DLLS did not. 
            Another important factor that may influence our choice of equipment is time and 
cost. Compared to NDGGE, DLLS is very fast and results can be obtained within very 
short time. It is very convenient to use. Though the price of equipment is high, the 
equipment incurs minimal maintenance cost. NDGGE on the other hand is very 
laborious and time consuming process. It takes more than 24 hours to obtain results from 
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this technique. Though the equipment itself is less expensive, the gels and standards are 
costly. For studies like our which require use of large number of gels and standards this 
may be a costly methods. Thus both NDGGE and DLLS have their own merits and 
demerits in measuring particle diameter and cost and time may be an important factor 
influencing the choice of equipment. 
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FIGURE 1. Formation of small dense LDL. Mild to moderate hypertriacyglyceridemia (HTG) leads to accumulation of large 
triacylglycerol rich VLDL (VLDL1) due to ovrproducton by liver or reduced clearance from circulation. Low Lipoprotein 
Lipase (LpL) activity or an excess of apoCIII (CIII; inhibitor of LpL) can impede the efficient lipolysis of VLDL1. VLDL1 
when lipolysed produce a population of Low density lipoprotein (LDL) particles (denoted β) which have an altered apoB100 
configuration.These particles do not bind well with LDL receptors and so habe prolonged residence time (Rt) in the 
circulation(d=day).Pool prolonged Retention (RT) in the circulation (d=days). Pool β LDL has therefore increased likelihood 
of undergoing remodelling. CETP removes cholesteryl ester (CE) and replaces it with triacylglycerol as the protein shuttle 
between VLDL, LDL and HDL particles. Triacylglycerol-enriched LDL is a good substrate for HL, an enzyme that removes 
triacylglycerol from smaller lipoprotein particles. Small, dense LDL is generated in this final lipolytic step. 
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FIGURE 2. Formation of small dense HDL. Lipid poor pre-beta high density lipoprotein acquires phospholipids and 
unesterified cholesterol (UC) from peripheral tissues to form discidal HDL (pre-beta). Lecitin:cholesterol 
acyltransferase(LCAT) facilitates exchange of UC for cholesterol ester (CE) in discoidal HDL to form spherical HDL. 
Cholesterol ester partition into center of thesespherical HDL which increases in size to form large HDL. Cholesterol ester 
transfer protein transfers CE from large HDL to Very Low Density Lipoprotein (VLDL) and Intermediate Density 
Lipoprotein (IDL).  
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FIGURE 3: Comparison of homodyne and heterodyne configuration used in Dynamic Laser Light Scattering. Io represents 
the reference beam which is reflected back from the sapphire window. Is represents the scattered light from the suspended 
particles. 
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FIGURE 4. Controlled Reference Method used in Nanotrac. The wave guide includes the optical splitter, fiber optic 
connector and the enclosed stainless probe. A part of the laser beam does not penetrate into the suspended particle and is 
reflected back from the sapphire window. Another part strikes the suspended particle and are scattered. 
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FIGURE 5. Experimental design of the study. Study was done in crossover design and was conducted in 3 phases. Each 
group consumed each of the three different diets at different phases. Each baseline and endpoint  consisted of 2 collections.                
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               FIGURE 6. Correlation between Mean Volume LDL diameter from DLLS and Mean diameter from NDGGE. 
               Chicken VLDLy measured by DLLS  was used as a standard for obtaining LDL diameter by NDGGE. 
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                 FIGURE 7. Correlation between Mean Number LDL diameter from DLLS and Mean diameter from NDGGE. 
                 Chicken VLDLy measured by DLLS was used as a standard for obtaining LDL diameter by NDGGE. 
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                    FIGURE 8. Correlation between Mean Area LDL diameter from DLLS and Mean diameter from NDGGE. 
                   Chicken VLDLy measured by DLLS was used as a standard for obtaining LDL diameter by NDGGE. 
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FIGURE 9. Correlation between Median Number LDL diameter from DLLS and Mean diameter from NDGGE.                           
Chicken VLDLy measured by DLLS was used as a standard for obtaining LDL diameter by NDGGE. 
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             FIGURE 10. Correlation between Mean volume HDL diameter from DLLS and Mean HDL diameter from NDGGE. 
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             FIGURE 11. Correlation between Mean number HDL diameter from DLLS and Mean HDL diameter from NDGGE. 
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                  FIGURE 12. Correlation between Mean area HDL diameter from DLLS and Mean HDL diameter from NDGGE.
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           FIGURE 13. Correlation between Median number HDL diameter from DLLS and Mean HDL diameter from NDGGE. 
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 TABLE 1. Lipoprotein characteristics found in human plasma  
   Chylomicron VLDL IDL LDL HDL  
 Density ( g/ml) <0.95 <1.006 
1.006-
1.019 
1.019-
1.063 
1.063-
1.210  
 
Particlediameter 
( nm) 1200-75 80-30 35-25 25-18 12-5  
 
Particle Mass 
( kD) 400,000 
10,000-
80,000 
5,000-
10,000 2,300 175-300  
 % Proteina 1.5-2.5 5-10 15-20 20-25 40-55  
 % Phospholipida 7-9 15-20 22 15-20 20-35  
 
% Free 
Cholestrola 1-3 5-10 8 7-10 3-4  
 
% 
Triaclyglycerideb 84 - 89 50-65 22 7-10 3-5  
 
% Cholesterol 
Esterb 3-5 10-15 30 35-40 12  
 
Major 
Apolipproteins 
AI, AII, 
B48, CI 
B100, CI, 
CII, 
B100, 
CIII, E B100 
AI, AII, 
CI, CII,  
   CII, CIII, E CIII, E     CIII, D, E  
                 VLDL= Very Low Density Lipoprotein 
                       IDL= Intermediate Density Lipoprotein 
                     LDL= Low Density Lipoprotein 
                       HDL= High Density Lipoprotein 
                       aSurface Component 
                       bCore Lipids 
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                      LDL= Low Density Lipoprotein 
TABLE 2. Low Density Lipoprotein characteristics found in human plasma 
  LDL-I  LDL-II  LDL-III  LDL-IV 
         
 Peak Sf 12-Jul  07-May  05-Mar  0-3 
 Density(gm/ml) 
1.019-
1.023  
1.023-
1.028  
1.034-
1.041  
1.044-
1.051 
    
1.028-
1.034  
1.041-
1.044  1.051-1.06 
 Diameter (nm) 27.2-28.5  26.5-27.2  24.7-25.6  23.3-24.2 
    25.6-26.5  24.2-24.7  22.0-23.3 
 %Protein 18  19  22  26 
    21  24  29 
 % Cholestrol ester 43  45  46  42 
    45  44  40 
 %Unesterified cholestrol 9  10  8  7 
    9  7  7 
 %Triacylglycerol 7  4  3  5 
    3  3  6 
 %Phospholipid 22  23  21  19 
       22   21  18 
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TABLE 3. High Density Lipoprotein characteristics found in human plasma   
     HDL2b    HDL3     
        HDL3L   HDL3D   
 Density ( g/ml)  1.063-1.125  1.1.3-1.14  1.15-1.16  
 Particlediameter ( nm)  9.5-12  5.5-9.5  5.5-9.5  
 Particle Mass ( kD)  358,000  182,000  152,000  
 % Protein  37  50  59  
 % Phospholipid  30  27  23  
 % Free Cholestrol  5  3  2  
 % Triaclyglyceride  8  5  3  
 % Cholesterol Ester  20  15  13  
 Major Apolipproteins  A-I, A-II  A-I, A-II  A-I, A-II  
  Minor Apolipoproteins  C-I, C-II.C-III,E  C-I, C-II.C-III,E       C-I,C-II, C-III, E   
 
        HDL2b = Large high density lipoprotein 
        HDL3 = Small High Density Lipoprotein 
       HDL3L, HDL3D = Subpopulation of  small high density lipoprotein 
          aSurface components 
          bCore lipids 
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TABLE 4. Baseline characteristics of plasma lipids and apolipoproteins according to the apoE 
genotypes 
  ApoE 4/3 ApoE 3/3 ApoE 3/2 
  
LDL size(nm) 26.3 ± 0.2a 25.8 ± 0.1b 25.7 ± 0.2b 
Values are mean ± SD        
Means in a row with superscripts without a common letter differ, P < 0.05   
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TABLE 5. Fat composition of the experimental diet 
 
 
 
 
 
 
 
                            
 
 
 
 
                                                        aAll diets contained a calorie distribution of 35% fat, 48% carbohydrate, and 17%  
                                      protein. 
                                                         bOleinate is oleic acid-rich safflower oil. 
 
 
aFat for Each Experimental Group and Diet Period (g/100 g) 
Period Saturated  Monounsaturated Polyunsaturated 
1 Lard 15.6 Oleinateb 9.8 Safflower oil 9.8 
1 Safflower oil 0.8 Lard 6.6 Lard 6.6 
2 Palm oil 15.4 Oleinate 16.4 Safflower oil 16.4 
2 Safflower oil 1     
  
   
                                                                                                                                                                        
 
 
81 
 
 
 
 
TABLE 6. Composition of ground patties. 
 
 
 
 
 
 
 
 
 MUFA = Monounsaturated Fatty Acid 
 SFA = Saturated Fatty Acid 
 
Ground patties MUFA:SFA 
1 0.8 
2 1.1 
3 1.4 
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TABLE 7. Nomenclature for labeling six baseline samples and six endpoint samples at three study phase. 
 Draw Phase I Draw Phase II Draw Phase III 
Baseline 1 1 P1B1 5 P2B1 9 P3B1 
Baseline 2 2 P1B2 6 P2B2 10 P3B2 
Endpoint 1 3 P1E1 7 P2E1 11 P3E1 
Endpoint 2 4 P1E2 8 P2E2 12 P3E2 
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TABLE 8. Particle and fluid information fed into Nanotrac®UPA 250 
 
  
Particle 
Information Fluid information 
  RI Density RI Viscosity 
        26°C 20°C 
VLDL+IDL 1.46 1 1.337 1.0197 1.0224 
LDL 1.46 1.02 1.344 0.9087 1.0462 
HDL 1.46 1.15 1.3685 1.065 1.226 
VLDL= Very Low Density Lipoprotein 
IDL = Intermediate Density Lipoprotein  
LDL = Low Density Lipoprotein  
HDL = High Density Lipoprotein  
 RI = Refractive Index
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TABLE 9. Number of data that were excluded from the study 
 Exclusion criteria P1B1 P1B2 P1E1 P1E2 P2B1 P2B2 P2E1 P2E2 P3B1 P3B2 P3E1 P3E2 
LDL Incomplete 1 1 0 1 1 4 1 1 1 1 2 2 
 MN < 16nm 1 1 1 0 0 0 0 0 0 0 0 0 
HDL Incomplete 1 1 0 1 1 4 1 1 1 1 2 2 
 MN < 7nm or MN > 14nm 0 4 1 1 2 8 2 5 2 5 2 4 
LDL= Low Density Lipoprotein  
HDL = High Density Lipoprotein  
MV = Mean Volume Diameter 
MN  = Mean Number Diameter 
MA = Mean Ares Diameter 
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TABLE 10. Loading Factor and Concentration Index of included and excluded data 
 HDL (n=30)  LDL (n=30) 
 Included Data Excluded Data p value  Included Data Excluded Data p value 
LF 0.009±0.003 0.01±0.01 <.05  0.1±0.02 0.1±0.1 >0.05 
CI 0.3±0.1 0.8±0.4 <.05  0.7±0.3 1.0±0.5 <0.05 
LF= Loading Index 
CI= Concentration Index 
Included Data = MN between 7nm and 14 nm for HDL 
MN greater than 16 nm for LDL 
Excluded Data = MN less than 7nm or greater than 14 nm for HDL 
MN less than 16 nm for LDL 
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TABLE 11. Covariance within and in between runs for NDGGE and within runs for DLLS 
NDGGE 
 LDL   HDL   
Std Within runs Between runs  Within runs Between runs 
T 5.7 4.3  14.1 11.1  
F 4.7 3.9  8.9 7.8  
C 4.3 4.4  6.4 5.0  
LDH    5.3 4.5  
BSA    4.5 4.0  
DLLS (within runs) 
 LDL    HDL  
MV MN MA  MV MN MA 
2.6 2.7 2.5  4.3 5.3 4.9 
                                        
                                      NDGGE = Non Denaturing Gradient Gel 
                                      DLLS = Dynamic Light Scattering 
                                      LDL= Low Density Lipoprotein  
                                      HDL = High Density Lipoprotein
  
   
                                                                                                                                                                        
 
 
87 
 
  
  
 
avalue is mean ± SD 
NDGGE = Non Denaturing Gradient Gel 
DLLS = Dynamic Light Laser Scattering 
LDL= Low Density Lipoprotein  
HDL = High Density Lipoprotein  
 
 
 
TABLE 12. Mean diameter of LDL and HDL as measured by NDGGE and DLLS 
  LDL   HDL       
          DLLS         p NDGGE p DLLS NDGGE p     
  19.1±1.4 26.2±1.4 <0.0001 9.8±1.6 9.8±0.7 >0.05     
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                                               TABLE 13. Comparison between baseline pairs and between endpoint pairs               
 Baseline LDL Endpoint 
Method 1* 2 p 3 4 p 5 6 p 7 8 p 9 10 p 11 12 p 
              
21.2 20.5 19.9 19.9 20 20.5 19.8 20.4 20 19.8 19.8 19.6 
DLLS ±1.2 ±1.8 >0.05 ±1.0 ±1.0 >0.05 ±1.1 ±0.8 >0.05 ±1.0 ±0.8 <0.05 ±0.9 ±1.2 >0.05 ±1.0 ±1.0 >0.05 
             
25. 9 25.7 26.6 26.3 25.1 25.8 27. 2 27.1 26. 0 26.4 27. 2 26.7 
NDGGE ±0.7 ±0.8 >0.05 ±1.9 ±1.2 >0.05 ±1.8 ±1.2 >0.05 ±1.3 ±1.6 >0.05 ±1.0 ±1.5 >0.05 ±1.3 ±1.2 <0.05 
  
 Baseline HDL Endpoint 
Method 1 2 p 3 4 p 5 6 p 7 8 p 9 10 p 11 12 p 
              
9.6 8.7 10.1 8.8 10.6 9 9.9 9.6 9.4 9.4 11.8 11.8 
DLLS ±1.4 ±1.1 >0.05 ±1.6 ±3.1 >0.05 ±1.6 ±1.1 <0.05 ±1.8 ±1.1 >0.05 ±1.3 ±1.2 >0.05 ±1.5 ±1.6 >0.05 
             
9. 9 9. 9 9.5 10. 0 9.5 9.3 9.3 9.4 10.3 10.2 9. 9 9.9 
NDGGE ± 0.6 ±.0.7 >0.05 ±.0.6 ± 1.1 <0.05 ± 0.6 ± 0.6 >0.05 ± 0.6 ± 0.7 >0.05 ± 0.5 ± 0.6 >0.05 ± 0.7 ±0.7 >0.05 
*Draw Number                  
NDGGE = Non Denaturing Gradient Gel               
DLLS = Dynamic Light Laser Scattering               
LDL= Low Density Lipoprotein                
HDL = High Density Lipoprotein                
n = Sample size                  
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              TABLE 14. Chicken VLDLy diameter as measured by DLLS and NDGGE 
 
 
 
DLS (nm) 
NDGGE (nm) MV MN MA 
34.9 28.5 23.7 26.1 
34.1 30.7 23.5 26.6 
41.7 30.7 23.5 26.6 
37.7 31.3 26.1 28.7 
40.3 31.3 26.1 28.7 
          NDGGE = Non Denaturing Gradient Gel 
        DLLS = Dynamic Light Laser Scattering 
        MV = Mean Volume Diameter 
        MN = Mean Number Diameter 
        MA = Mean Ares Diameter 
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TABLE 15. Mean LDL diameter obtained from different standard curves  
  With VLDLy Std With VLDLy Std Rf/Log(r) 
Without VLDLy 
Std 
measured by 
NDGGE measured by DLLS 
             
        
26.0±1.3   25.8± 1.1   18.4± 1.0   27.1±1.5 
                                      
                                        VLDLy= Chicken Very Low Density Lipoprotein 
                                        NDGGE= Non Denaturing Gel Electrophoresis 
                                        DLLS= Dynamic Laser Light Scattering 
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avalue is mean ± SD 
 
TABLE 16. Peak width comparison between DLLS samples which showed one or two 
bands  in NDGGE  
  1 bands in NDGGE 2 bands in NDGGE      
Peak width 2 nm±.0005a 2 nm±.0006    
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TABLE 17. Effect of storage on LDL diameter for 3 collections 
Method  DLLS   NDGGE  
Days stored prior to 
analysis 0 4 p 0 4 p 
Phase I endpoint 19.8 19.3 >0.05 26.3 25.8 0.05 
Phase II baseline 19.9 20.0 >0.05 25.7 25. 1 0.05 
Phase III baseline 19.0 21.0 <0.05 25.4 26.8 <0.05 
                                    NDGGE = Non Denaturing Gradient Gel 
                              DLLS = Dynamic Laser Light Scattering 
      LDL= Low Density Lipoprotein  
                              HDL = High Density Lipoprotein  
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TABLE 18. Effect of storage on HDL diameter for 2 collections 
Method  DLLS   NDGGE  
Days stored prior to 
analysis 0 4 p 0 4 p 
Phase I endpoint 8.2 9.8 0.05 9.4 8.9 <0.05 
Phase II baseline 9.4 8.3 >0.05 9.4 9.1 <0.05 
                                    NDGGE = Non Denaturing Gradient Gel 
                              DLLS = Dynamic Laser Light Scattering 
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                           TABLE 19. Effect of storage on LF and CI in DLLS 
 
 
 
 
 
 
 
 
LF= Loading Factor 
CI= Concentration Index 
LDL= Low Density Lipoprotein  
HDL = High Density Lipoprotein  
 
  
 HDL (n=30)  LDL (n=30) 
Days stored prior to 
analysis 0 4 p   0 4 p  
LF 0.01±0.0 0.01±0.0 >0.05  0.1±0.2 0.1±0.0 >0.05 
CI 0.3±0.1 0.7±1.3 >0.05  0.7±0.3 0.8±0.3 >0.05 
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